Prostate Cancer Screening Decisions | Zendy

Richard M. Hoffman | Zendy; Mick P. Couper | Zendy; Brian J. ZikmundFisher | Zendy; Carrie A. Levin | Zendy; Mary McNaughtonCollins | Zendy; Deborah Helitzer | Zendy; John VanHoewyk | Zendy; Michael J. Barry | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prostate Cancer Screening Decisions

Author(s) -

Richard M. Hoffman,

Mick P. Couper,

Brian J. ZikmundFisher,

Carrie A. Levin,

Mary McNaughtonCollins,

Deborah Helitzer,

John VanHoewyk,

Michael J. Barry

Publication year - 2009

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinternmed.2009.262

Subject(s) - medicine , prostate cancer screening , odds ratio , confidence interval , prostate cancer , family medicine , prostate specific antigen , odds , health care , cancer , cancer screening , gynecology , national health interview survey , logistic regression , population , environmental health , economics , economic growth

Guidelines recommend informing patients about the risks and benefits of prostate cancer screening. We evaluated the medical decision-making process for prostate-specific antigen (PSA) testing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research